VKTX: Viking Therapeutics Inc. Stocks News on February 22, 2025

VKTX

Insider Monkey

13 hours ago

Why Viking Therapeutics Inc. (VKTX) Surged On Friday?

VKTX

Insider Monkey

3 days ago

Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday?

VKTX

MT Newswires

9 days ago

Scotiabank Initiates Viking Therapeutics at Sector Outperform

VKTX

Insider Monkey

11 days ago

Why Viking Therapeutics Inc. (VKTX) Went Down on Monday

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

VKTX

Motley Fool

12 days ago

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today

VKTX

Motley Fool

12 days ago

2 Stocks to Buy With Less Than $40

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

VKTX

Motley Fool

12 days ago

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

The M&A boom of 2025 is just getting started — and here are 5 potential targets

VKTX

MarketWatch

14 days ago

The M&A boom of 2025 is just getting started — and here are 5 potential targets

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

VKTX

TipRanks

14 days ago

Viking Therapeutics price target lowered to $96 from $109 at B. Riley

VKTX

Motley Fool

14 days ago

2 Stocks That Could Soar Again in 2025

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?

VKTX

Motley Fool

14 days ago

Down 65%, Is Viking Therapeutics Stock a Buy on the Dip?

VKTX

MT Newswires

15 days ago

B. Riley Adjusts Price Target on Viking Therapeutics to $96 From $109, Keeps Buy Rating

VKTX

MT Newswires

15 days ago

Citigroup Initiates Viking Therapeutics at Neutral With $38 Price Target

VKTX

MT Newswires

15 days ago

Truist Securities Adjusts Viking Therapeutics Price Target to $95 From $120, Maintains Buy Rating

The Drug Industry Is Having Its Own DeepSeek Moment

VKTX

The Wall Street Journal

15 days ago

The Drug Industry Is Having Its Own DeepSeek Moment

Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why.

VKTX

Investor's Business Daily

16 days ago

Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why.

Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials

VKTX

GuruFocus.com

16 days ago

Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials

Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.

VKTX

Investor's Business Daily

16 days ago

Viking Therapeutics Plummeted 8% On Its Earnings Report. Here's Why.

VKTX

Zacks

16 days ago

VKTX's Q4 Loss Wider Than Expected, Sales Nil, Stock Down 10%

Has the Bubble Burst for Viking Therapeutics Stock?

VKTX

Motley Fool

16 days ago

Has the Bubble Burst for Viking Therapeutics Stock?

VKTX

Thomson Reuters StreetEvents

16 days ago

Q4 2024 Viking Therapeutics Inc Earnings Call

VKTX

GuruFocus.com

16 days ago

Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...

VKTX

Insider Monkey

17 days ago

Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

VKTX

PR Newswire

17 days ago

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

VKTX

Zacks

17 days ago

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?

VKTX

Insider Monkey

18 days ago

Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?

VKTX

Insider Monkey

20 days ago

Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”

This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?

VKTX

Motley Fool

20 days ago

This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?

VKTX

Insider Monkey

22 days ago

Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’

VKTX

Zacks

23 days ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

VKTX

Zacks

23 days ago

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

VKTX

Investor's Business Daily

a month ago

Novo Nordisk Surges As Next-Gen Obesity Drug Outperforms

Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results

VKTX

Investor's Business Daily

a month ago

Novo Nordisk Jumps On Experimental Weight-Loss Drug Trial Results

This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly.

VKTX

Barrons.com

a month ago

This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly.

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?

VKTX

Motley Fool

a month ago

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?

VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Increases Yet Falls Behind Market: What Investors Need to Know

VKTX

Quartz

a month ago

The race for the next Ozempic is on

VKTX

Zacks

a month ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

VKTX

Insider Monkey

a month ago

Why Viking Therapeutics, Inc. (VKTX) Crashed Last Week

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

VKTX

Motley Fool

a month ago

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today

VKTX

Insider Monkey

a month ago

Why Viking Therapeutics (VKTX) Is the Biotech Stock with Biggest Upside Potential

VKTX

Zacks

a month ago

NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow Down

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

VKTX

BioPharma Dive

a month ago

JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

VKTX

Motley Fool

a month ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

VKTX

Investor's Business Daily

a month ago

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment

VKTX

Clinical Trials Arena

a month ago

Viking Therapeutics begins VK2735 Phase II trial for obesity treatment

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

VKTX

Zacks

a month ago

Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug

3 Mid-Cap Stocks That Could Take Off in 2025

VKTX

Motley Fool

a month ago

3 Mid-Cap Stocks That Could Take Off in 2025

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

PR Newswire

a month ago

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Stock Sinks As Market Gains: What You Should Know

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

VKTX

PR Newswire

2 months ago

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Why Viking Therapeutics Stock Plummeted by 24% in December

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Plummeted by 24% in December

VKTX

Zacks

2 months ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

From Davids to Goliaths: the GLP-1RA gold rush

VKTX

Pharmaceutical Technology

2 months ago

From Davids to Goliaths: the GLP-1RA gold rush

Should You Buy the Dip on This High-Flying Stock?

VKTX

Motley Fool

2 months ago

Should You Buy the Dip on This High-Flying Stock?

VKTX

Zacks

2 months ago

VKTX Stock Loses More Than 20% in Six Months: Should You Buy the Dip?

VKTX

Insider Monkey

2 months ago

Why Is Viking Therapeutics, Inc. (VKTX) Among the Best Multibagger Stocks to Buy Right Now?

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors

3 Stocks That Could Be Monster Winners in 2025

VKTX

Motley Fool

2 months ago

3 Stocks That Could Be Monster Winners in 2025

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know

VKTX

Insider Monkey

2 months ago

Will Viking Therapeutics, Inc. (VKTX) Make You Rich In 2025?

3 biggest catalysts expected for healthcare in 2025

VKTX

Yahoo Finance Video

2 months ago

3 biggest catalysts expected for healthcare in 2025

VKTX

Insider Monkey

2 months ago

Is Viking Therapeutics, Inc. (VKTX) the Best Performing Biotech Stock in 2024?

Hot Obesity Drug Market Will Keep Investors Gripped Next Year

VKTX

Bloomberg

2 months ago

Hot Obesity Drug Market Will Keep Investors Gripped Next Year

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

VKTX

Motley Fool

2 months ago

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

VKTX

Motley Fool

2 months ago

My Top 10 Stocks to Buy for 2025

Why Viking Therapeutics Tumbled by More Than 10% This Week

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Tumbled by More Than 10% This Week

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

VKTX

Investor's Business Daily

2 months ago

Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge.

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

VKTX

Motley Fool

2 months ago

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up

VKTX

MT Newswires

2 months ago

Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

VKTX

Investor's Business Daily

2 months ago

Novo Crashes 20% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump.

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

VKTX

Zacks

2 months ago

Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug

VKTX

Simply Wall St.

2 months ago

Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth

VKTX

Zacks

2 months ago

Here's Why VKTX Stock Plummeted 18% on Wednesday

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else

VKTX

Investor's Business Daily

2 months ago

Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else

VKTX

Insider Monkey

2 months ago

Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today?

What's Going On With Viking Therapeutics Stock On Wednesday?

VKTX

Benzinga

2 months ago

What's Going On With Viking Therapeutics Stock On Wednesday?

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

VKTX

Barrons.com

2 months ago

Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.

VKTX

Insider Monkey

2 months ago

Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

VKTX

Investor's Business Daily

2 months ago

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

VKTX

Motley Fool

2 months ago

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

VKTX

Motley Fool

2 months ago

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street

VKTX

Zacks

2 months ago

Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know

Warning: This Skyrocketing Stock Has a Hidden Risk

VKTX

Motley Fool

2 months ago

Warning: This Skyrocketing Stock Has a Hidden Risk

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

VKTX

Motley Fool

3 months ago

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

VKTX

Motley Fool

3 months ago

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

2 Disruptive Growth Stocks With Room to Run

VKTX

Motley Fool

3 months ago

2 Disruptive Growth Stocks With Room to Run

VKTX

MT Newswires

3 months ago

Piper Sandler Initiates Viking Therapeutics at Overweight

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

VKTX

Motley Fool

3 months ago

Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

VKTX

Investor's Business Daily

3 months ago

Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

VKTX

MT Newswires

3 months ago

Amgen Obesity Drug Falls Short of Efficacy Expectations in Trial, Mizuho Says; Shares Decline

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment

VKTX

Investor's Business Daily

3 months ago

Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

VKTX

Motley Fool

3 months ago

Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst

VKTX

Motley Fool

3 months ago

3 Monster Stocks in the Making

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

VKTX

Investor's Business Daily

3 months ago

RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

VKTX

Zacks

3 months ago

Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report?

VKTX

Zacks

3 months ago

VKTX Stock Loses Over $1B in a Month: How to Play the Stock?

VKTX

MT Newswires

3 months ago

Latest Viking Therapeutics Inc. (VKTX) News on February 22, 2025

Share on Social Networks: